| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |